For Quick Alerts
For Daily Alerts

Supreme Court disallows patent to Novartis cancer drug


Supreme Court disallows patent to Novartis cancer drug
Novartis India: Quotes, News
BSE 565.80BSE Quote3.9 (-0.69%)
The Supreme Court today denied a patent to Swiss giant Novartis AG's cancer treatment Glivec. The stock of Novartis was down almost 5 per cent following reports of the ruling.

It was last trading at Rs 572, after plunging to a 52-week low of Rs 558 on the Bombay Stock Exchange.

Today's ruling comes as a setback to many renowned global pharma companies that are looking at India to boost sales.

Shares of domestic pharma companies who are large exporters like Aurobindo Pharma and Orchid Chemicals jumped following today's Supreme Court ruling. Dr Reddy's Labs was also trading higher by 2.26 per cent.

Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.

Headquartered in Basel, Switzerland, Novartis employs nearly 115 000 people in over 140 countries worldwide to help save lives and improve the quality of life.

The Group is present in India through Novartis India Limited, listed on the Mumbai Stock Exchange and its wholly owned subsidiaries Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron Behring Vaccines Private Limited.

Read more about: novartis
Story first published: Monday, April 1, 2013, 11:15 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more